Nabeel Bardeesy, Ph.D. | Bardeesy.Nabeel@mgh.harvard.edu
Associate Professor of Medicine at Harvard Medical School
Faculty at the MGH Center for Cancer Research
Affiliated Faculty at the MGH Center for Regenerative Medicine
Nabeel grew up in Eastern Canada and received B.Sc. and PhD. degrees from McGill University in Montreal. He did postdoctoral studies at the Dana-Farber Cancer Institute/Harvard Medical School in the laboratory of Ron DePinho. He is presently Associate Professor of Medicine at Harvard Medical School and Massachusetts General Hospital Cancer Center where he holds the Gallagher Endowed Chair in Gastrointestinal Cancer Research.
Filippos Kottakis, Ph.D. | email@example.com
Filippos did his BSc and PhD in Chemistry in Aristotle University of Thessaloniki, Greece. For his thesis, he studied the anti-inflammatory properties of natural products for the treatment of H. pylori infection. He subsequently did doctoral training at Tufts Medical Center where he focused on linking signaling pathways to epigenetic regulators and their interplay in cancer. He joined the Bardeesy Lab at 2012 and he is currently working on defining the role of multiple tumor suppressors in pancreatic cancer.
Krushna Patra, Ph.D. | firstname.lastname@example.org
Originally from India, Krushna received his M.Tech degree from Indian Institute of Technology, India and PhD degree from University of Illinois at Chicago, USA. In his graduate study with Dr. Nissim Hay he studied the contributions of metabolic enzymes in oncogenesis process in different mouse models of cancer. In Bardeesy lab he is currently studying metabolic reprogramming in the progression of pancreatic cancer precursors.
Yasutaka (Taka) Kato, M.D., Ph.D. | email@example.com
Taka received his MD - PhD from Hokkaido University in Japan. He had been engaged in Pathology for 7 years and his area of expertise is in gastrointestinal cancer and disease in central nervous system, including tumors and neurodegenerative disease. During his graduate study, Taka studied the contribution of Cyclooxygenase-2 in various tumors. He joined the Bardeesy lab in June 2015. His current research focuses on screening of oncology drugs for pancreatic cancer using three-dimensional culture techniques.
Jia-Chi Yeo, Ph.D. | firstname.lastname@example.org
Jia-Chi is from Singapore and he received his Ph.D. in Biological Sciences from the Nanyang Technological University. During his graduate studies, he studied the role of Klf2 and Mek/Erk-signaling during mouse ground state pluripotency. Joining the Bardeesy Lab in 2015 for his post-doctoral research, Jia-Chi is currently researching on the role of transcriptional/epigenetic regulation in cholangiocarcinoma.
Leah Liu, Ph.D. | Leah.Liu@mgh.harvard.edu
Leah completed her BS at Penn State University and her PhD in Biological and Biomedical Sciences at Harvard University, where she studied liver development and liver injury using the zebrafish model. In the Bardeesy Lab, Leah is studying the role of FGFR2 mutations in cholangiocarcinoma.
Lei Shi, Ph.D. | LSHI7@mgh.harvard.edu
Lei received his BS degrees from China Agricultural University and Purdue University. He then obtained his PhD degree in Biochemistry at University of Texas Southwestern Medical Center. Under the guidance of Dr. Benjamin Tu, he studied the metabolic regulation of cell growth and quiescence in yeast. Upon completion of his PhD degree, he joined the Bardeesy lab and continued to pursue his interest in metabolism and biochemistry. Currently, he is studying the biochemical mechanisms of IDH mutations in cholangiocarcinoma.
Krishna Tummala, Ph.D. | email@example.com
Krishna did his MS in Biotechnology at Indian Institute of Technology Roorkee. He continued his graduate training at Spanish National Cancer Research Centre (CNIO) on liver cancer under the supervision of Dr. Nabil Djouder. His PhD work focused on the cellular and molecular mechanisms of hepatocarcinogenesis in vivo. He joined Dr. Bardeesy lab in April 2016 to study the role of sub-cellular organelles in pancreatic cancer development using sophisticated in vitro cell systems.
Vajira Weerasekara, Ph.D. | VWEERASEKARA@mgh.harvard.edu
Vajira received his BS degree in Biochemistry and Molecular Biology from University of Colombo, Sri Lanka. He then obtained his Ph.D. in Biochemistry under the supervision of Dr. Joshua Andersen at Brigham Young University, Provo, Utah. His Ph.D. thesis focused on the changes in phosphoproteome as a response to tumor hypoxia. He joined the Bardeesy lab in 2017 to study tumorigenesis and progression of pancreatic cancer using in vivo and in vitro systems.
Other Lab Memmbers
Phuong Vu, B.Sc. | Technician | firstname.lastname@example.org
Originally from Vietnam, Vu received her BS degree in Biochemistry from Worcester Polytechnic Institute, MA. Her senior thesis focused on the importance of the C-terminal extended region of Porcine Circovirus 1 VP3 in inducing apoptosis of human cancer cells. Currently, she assists Shoop in examining the effect of isocitrate dehydrogenase mutations on bile duct cancer.
Nicole Smith, B.A. | Lab Manager | email@example.com
Nicole, our lab manager, is a lifelong resident of Massachusetts. She was born in Medford and graduated from Merrimack College with a degree in Biology. She been working at Massachusetts General Hospital for 20 years where she developed expertise in monoclonal antibody production and molecular biology.
- Kuang-Hung Cheng, Ph.D. (National Sun Yat-sen University, Kaohsiung, Taiwan)
- Sushma Gurumurthy, Ph.D. (Dana-Farber Cancer Institute, Boston, MA)
- Justin Berger, B.S. (Albert Einstein School of Medicine, Bronx, NY)
- Ruben Plentz, M.D. (Medizinische Universitätsklinik, Tübingen, Germany)
- Aram Hezel, M.D. (University of Rochester, Rochester, NY)
- Annie Moisan, Ph.D. (Roche Pharmaceuticals, Basel, Switzerland)
- Satish Sankaran, Ph.D. (Associate Director of Lab Operations at Strand Life Sciences, Banglore, India)
- Li Zhang, Ph.D. (Regeneron Pharmaceuticals, Tarrytown, NY)
- Patty Zadnik, B.S. (Johns Hopkins Medical School)
- Stephanie Madden, B.S. (Stanford University)
- Rashmi Ahuja, Ph.D. (University of Helsinki, Helsinki, Finland)
- Judy Kim, B.S. (Dartmouth Medical School)
- Gianmarco Contino, M.D. (University of Chicago)
- Brinda Alagesan, B.S.(SUNY Stony Brook Medical School)
- Afamefuna Nduaguba, B.Sc. (Harvard Medical School)
- Polina Paskaleva, B.S. (College of Osteopathic Medicine, NYIT, Long Island, NY)
- Krishna Sumanth Ghanta, M.S. (UMass Medical School, PhD Student, Worcester, MA)
- Alexandros (Alex) Tzatsos, Ph.D. (George Washington University, Faculty, Washington, DC)
- Yusuke Mizukami, M.D., Ph.D., Visiting Scientist (Chief in Regenerative Medicine and Cancer Research, Center for Clinical and Biomedical Research, Sapporo Higashi Tokushukai Hospital)
- Julia Nagle, B.A. (University of Kentucky Medical School, KY)
- Christine Parachoniak, Ph.D. (Foundation Medicine, MA)
- Mortada Najem, B.S. (Syros Pharma., MA)
- Rushika Perera, Ph.D. (University of California - San Francisco, Assistant Professor, San Francisco, CA)
- Julien Fitamant, Ph.D. (Novartis Institute for Biomedical Research, Group Leader, Basal, Switzerland)
- Sebastian Widholz, B.S. (Friedrich-Alexander-University Erlangen-Nuremberg, Master Student, Bavaria, Germany)
- Supriya Saha, M.D., Ph. D. (Fred Hutchinson Cancer Research Center, Assistant Member, Seattle, WA)
- Marie-Camille Rowell, B.S. (University of Montreal, Ph.D. Student, Montreal, CA)